Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patientsDaniel Whittam, Brigitte Wildemann, Álvaro Cobo‐Calvo et al.|Multiple Sclerosis and Related Disorders|2020Cited by 179
Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorderNasrin Asgari, Brian G. Weinshenker, Eoin P. Flanagan et al.|Neurology Neuroimmunology & Neuroinflammation|2017Cited by 67
Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis AttacksJohn J. Chen, Romain Marignier, David O. Hodge et al.|American Journal of Ophthalmology|2023Cited by 64
De-escalating and discontinuing disease-modifying therapies in multiple sclerosisG. Androdias, Bruno Stankoff, Jan D. Lünemann et al.|Brain|2024Cited by 27
Spontaneous remyelination in lesions protects the integrity of surrounding tissues over time in multiple sclerosisVito A. G. Ricigliano, Benedetta Bodini, Mattéo Tonietto et al.|European Journal of Neurology|2022Cited by 24